What if the hardening of our arteries isn’t entirely inevitable?

A two-year study investigated whether vitamin K2 as MK-7 could influence the progression of coronary artery calcification in patients with symptomatic coronary artery disease. While calcification progressed in both groups, participants receiving 360 μg of MK-7 daily showed significantly slower progression compared with placebo.

In Episode 137 of the Orange Pill Podcast, we explore what the findings reveal about vitamin K2, developing versus established plaques, vascular vitamin K status, and why slowing calcification, not reversing it, could open an interesting new conversation about cardiovascular aging.